Technology & Telecommunication Acquisition held extraordinary shareholder meeting
Reuters2026/08/26 21:07- An extraordinary general meeting was held on Aug. 20, 2026.
- Shareholders adopted a charter amendment extending the business-combination deadline by six months to Feb. 20, 2027.
- Investors also adopted an amendment to the investment management trust agreement to permit the same extension.
- The trust agreement amendment was executed on Aug. 20, 2026 with Continental Stock Transfer & Trust Company.
- The charter amendment was authorized for filing in the Cayman Islands on Aug. 20, 2026; filing was not confirmed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Most panda coin types from the 2026 edition steadily rebounded in August
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
